News & Events

• January 21, 2021 - January 21, 2021
  

  Watch now: RDCA-DAP and EATRIS Present Rare Disease Drug Develoment Webinar

  January 21, 2021 | 5:00 p.m. – 6:30 p.m. CET
  Data Sharing and Analysis to Support Rare Disease Drug Development

  The European Infrastructure for Translational Medicine, EATRIS, has invited the Rare Disease Cures Accelerator-Data and Analytics Platform team to present as part of its webinar series, EATx, to introduce RDCA-DAP to the European academic and industry audience. The webinar will discuss how RDCA-DAP works with European entities and how data sharing within Europe, and between Europe and other countries, can be achieved with RDCA-DAP.

• October 19, 2020 - October 19, 2020
  

  Watch Now: RDCA-DAP 2020 Virtual Workshop

  Join us for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) annual workshop and learn more about:

  – RDCA-DAP’s first year progress and development
  – How RDCA-DAP will work to accelerate rare disease drug development
  – How the platform works: improved ability to search and sort data
  – Case studies on how sharing patient-level data accelerates understanding of rare diseases
  – Ways to get involved and the benefits of engaging with RDCA-DAP

  Monday, October 19, 11 a.m. – 3:30 p.m. ET. Watch now.

• September 18, 2020
  

  Watch Now: Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis Webinar

  Despite increasing numbers of drug targets and technologies, rare disease drug development is frequently slowed by the low numbers of patients and the lack of comprehensive quantitative characterization of diseases. Tucson’s Critical Path Institute (C-Path), along with the National Organization of Rare Disorders and the FDA, have developed an integrated database and analytics hub called the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) to help accelerate clinical development, make it less expensive, and encourage new companies to develop treatments for rare diseases.

  Presenters:

  Jane Larkindale, D.Phil. Critical Path Institute, Executive Director Rare Disease Cures Accelerator-Data and Analytics Platform; Duchenne Regulatory Science Consortium

  Vanessa Boulanger, MSc, National Organization for Rare Disorders, Director of Research Programs

  Michelle Campbell, PhD, U.S. Food and Drug Administration, Sr. Clinical Analyst for Stakeholder Engagement and Clinical Outcomes, Division of Neurology Products

  Part of Arizona Bioscience Week Educational Events | Watch AZBW2020

• June 24, 2020
  

  Watch now: Shortening the Timeline for Developing New Treatments – How the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) Can Help Webinar

  Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), an integrated database and analytics hub designed to be used in building novel tools to accelerate drug development across rare diseases.

  Wednesday, June 24 at 1 PM EDT. Watch now.

• May 6, 2020
  

  Watch now: What You Need to Know About the Rare Disease Cures Accelerator-Data and Analytics Platform Webinar

  Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), an integrated database and analytics hub designed to be used in building novel tools to accelerate drug development across rare diseases. Wednesday, May 6 at 1 PM EDT. Watch......